wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33846405-5B53873B-8B3B-4C23-9F9D-5D4528F09C5D
Q33846405-5B53873B-8B3B-4C23-9F9D-5D4528F09C5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33846405-5B53873B-8B3B-4C23-9F9D-5D4528F09C5D
A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
P2860
Q33846405-5B53873B-8B3B-4C23-9F9D-5D4528F09C5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33846405-5B53873B-8B3B-4C23-9F9D-5D4528F09C5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc28292e0391aa7f231a53de515de4b7f566d712
P2860
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors.